Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody Publication Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody The article titled "Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a…CertaraNovember 4, 2024
JSCPT 2025 – The 46th Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics Conference JSCPT 2025 – The 46th Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics We’re excited to participate in JSCPT 2025 in Tokyo, The 46th Annual Scientific Meeting of…CertaraOctober 31, 2024
Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women Publication Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women The article titled "Using PBPK modeling to supplement clinical data and support the safe and…CertaraOctober 30, 2024
On-ramps to popPK: Building Better Models with GUI, Code, or Both On-Demand Webinar On-ramps to popPK: Building Better Models with GUI, Code, or Both A critical component of popPK studies is popPK modeling, where mathematical models are developed to…CertaraOctober 18, 2024
A close examination of BCRP’s role in lactation and methods for predicting drug distribution into milk Publication A close examination of BCRP’s role in lactation and methods for predicting drug distribution into milk The article, authored by Caroline Sychterz, Hong Shen, Yueping Zhang, Michael Sinz, Amin Rostami-Hodjegan, Brian…CertaraSeptember 18, 2024
A tutorial on physiologically based pharmacokinetic approaches in lactation research Publication A tutorial on physiologically based pharmacokinetic approaches in lactation research The tutorial by Amita Pansari, Xian Pan, Lisa M. Almond, and Karen Rowland-Yeo examines the…CertaraSeptember 16, 2024
Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration Publication Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration The article from the European Journal of Pharmaceutical Sciences reviews the role of Physiologically Based…CertaraSeptember 1, 2024
Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator Publication Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator The article "Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system…CertaraAugust 26, 2024
Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH) Publication Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH) The article “Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL)…CertaraAugust 26, 2024
Certara Talks: PAGE 2024 PodcastVideo Certara Talks: PAGE 2024 Learn more about our Modeling & Simulation Services Transcript: Hello, and welcome to Certara…CertaraAugust 5, 2024